Trials / Not Yet Recruiting
Not Yet RecruitingNCT06832878
Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 101 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral Tranexamic Acid | Subjects will receive a 1.95 g dose of oral TXA at the following timepoints: (1) following ambulation, (2) postoperative day 1, (3) postoperative day 2, and (4) postoperative day 3 |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-02-18
- Last updated
- 2026-02-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06832878. Inclusion in this directory is not an endorsement.